XRTX
XORTX Therapeutics Inc.
NASDAQ · Healthcare · Biotechnology · CA
$2.42
+12.33%Next report
Analyst consensus
- Next report date
- Nov 12, 2026
- EPS estimate
- —
- Revenue estimate
- —
Latest reported
- Last report date
- Aug 17, 2026
- EPS actual
- -$1.05
- EPS estimate
- —
- Revenue actual
- —
- Revenue estimate
- —
Track record
Trailing twelve quarters
- EPS beats (12Q)
- 7
- EPS misses (12Q)
- 2
- EPS in line (12Q)
- 0
- Avg surprise (4Q)
- -57.2%
- Revenue beats (12Q)
- —
Reported results against consensus at the time of each report · Surprise is computed from the estimate on record · Data as of Nov 12, 2026